http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110669168-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08F220-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08F220-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08F230-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F220-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F220-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F230-02 |
| filingDate | 2019-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110669168-B |
| titleOfInvention | Modifying agent, preparation method and use method thereof and medical material |
| abstract | The invention discloses a modifier, which comprisesThe structural unit is shown in a formula (I), wherein R1 is a direct bond or alkylene or substituted alkylene with 1-5 carbon atoms, R2 is a direct bond or alkyl or substituted alkyl with 1-5 carbon atoms, R3 is a direct bond or alkyl or substituted alkyl with 1-5 carbon atoms, R4 is a direct bond, alkylene or substituted alkylene with 1-5 carbon atoms or acyloxy with 1-5 carbon atoms, R5 is a zwitterionic group, and the molecular weight of the modifier is 10 KDa-180 KDa. The invention also discloses a preparation method and a use method of the modifier and a medical material. |
| priorityDate | 2019-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 57.